MA45283A1 - A multivalent composition of pneumococcal polysaccharide-capsular transporter protein conjugates and use of that - Google Patents

A multivalent composition of pneumococcal polysaccharide-capsular transporter protein conjugates and use of that

Info

Publication number
MA45283A1
MA45283A1 MA45283A MA45283A MA45283A1 MA 45283 A1 MA45283 A1 MA 45283A1 MA 45283 A MA45283 A MA 45283A MA 45283 A MA45283 A MA 45283A MA 45283 A1 MA45283 A1 MA 45283A1
Authority
MA
Morocco
Prior art keywords
capsular
protein conjugates
transporter protein
pneumococcal polysaccharide
multivalent composition
Prior art date
Application number
MA45283A
Other languages
French (fr)
Other versions
MA45283B1 (en
Inventor
Tae Hyun Kim
Hoon Sung Jeh
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MA45283A1 publication Critical patent/MA45283A1/en
Publication of MA45283B1 publication Critical patent/MA45283B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne une composition de vaccin comprenant 13 ou 14 types de conjugués de protéine de transport de polysaccharide capsulaire pour la prévention de maladies à pneumocoque et une composition immunogène pour streptococcus pneumoniae.The present invention provides a vaccine composition comprising 13 or 14 types of capsular polysaccharide transport protein conjugates for the prevention of pneumococcal disease and an immunogenic composition for streptococcus pneumoniae.

MA45283A 2016-09-06 2017-08-31 A COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACCARID-CAPSULAR CARRIER PROTEIN COMBINES AND USE FROM THIS MA45283B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Publications (2)

Publication Number Publication Date
MA45283A1 true MA45283A1 (en) 2019-06-28
MA45283B1 MA45283B1 (en) 2021-05-31

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45283A MA45283B1 (en) 2016-09-06 2017-08-31 A COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACCARID-CAPSULAR CARRIER PROTEIN COMBINES AND USE FROM THIS

Country Status (12)

Country Link
KR (1) KR101991457B1 (en)
BR (1) BR112019004303A2 (en)
EA (1) EA201990451A1 (en)
JO (1) JOP20190038B1 (en)
MA (1) MA45283B1 (en)
MX (1) MX2019002552A (en)
MY (1) MY192792A (en)
PH (1) PH12019500377A1 (en)
SA (1) SA519401232B1 (en)
TN (1) TN2019000064A1 (en)
WO (1) WO2018048141A1 (en)
ZA (1) ZA201901969B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019139692A2 (en) 2017-12-06 2019-07-18 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
CA3089007A1 (en) 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019256218A1 (en) 2018-04-18 2020-12-03 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
MX2021007496A (en) 2018-12-19 2021-08-05 Merck Sharp & Dohme Llc Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof.
WO2023218322A1 (en) * 2022-05-11 2023-11-16 Pfizer Inc. Process for producing of vaccine formulations with preservatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3828145B2 (en) * 1993-09-22 2006-10-04 ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン A method for the activation of soluble carbohydrates using a novel cyanating reagent for the production of immunogenic components
EP2425854A1 (en) * 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
CN107080838A (en) * 2010-06-04 2017-08-22 惠氏有限责任公司 Bacterin preparation
KR102057217B1 (en) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN103893751B (en) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 A kind of pneumococal polysaccharide Protein Conjugation vaccine and preparation method thereof
CN104069504B (en) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 A method of enhancing polysaccharide protein conjugate immunogenicity

Also Published As

Publication number Publication date
EA201990451A1 (en) 2019-08-30
JOP20190038A1 (en) 2019-03-06
KR20180027353A (en) 2018-03-14
PH12019500377A1 (en) 2019-10-21
MY192792A (en) 2022-09-09
JOP20190038B1 (en) 2023-09-17
MA45283B1 (en) 2021-05-31
MX2019002552A (en) 2019-07-01
WO2018048141A1 (en) 2018-03-15
SA519401232B1 (en) 2022-10-23
ZA201901969B (en) 2019-12-18
TN2019000064A1 (en) 2020-07-15
BR112019004303A2 (en) 2019-05-28
KR101991457B1 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
MA45283A1 (en) A multivalent composition of pneumococcal polysaccharide-capsular transporter protein conjugates and use of that
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CY1123783T1 (en) ENANTI-B7-H3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
BR112020004471A8 (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
BR112020004396A8 (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
MX2022009928A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
MX2020002555A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
MX2019002968A (en) Fusion comprising a cell penetrating peptide, a multi epitope and a tlr peptide agonist for treatment of cancer.
EA201890400A1 (en) METHODS AND COMPOSITIONS FOR IMMUNE PROTECTION AGAINST EXTRAUCTAL PATHOGENIC E. COLI
MX2016003621A (en) Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3.
TN2015000402A1 (en) METHODS FOR TREATING CROHN'S DISEASE USING AN ANTI-IL23 ANTIBODY
WO2015175355A8 (en) Compositions and methods of enhancing immunogenicity of polysaccharide-protein conjugates
MX2020008454A (en) Immunogenic composition comprising staphylococcal antigens.
MA46661B1 (en) GLYCOCONJUGATE VACCINE FORMULATIONS DIRECTED AGAINST EXPEC
CO2021007863A2 (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
MX2022001937A (en) Immunogenic composition.
AR114693A1 (en) VACCINES AGAINST INTRAABDOMINAL INFECTIONS
TH175548A (en) Hand, foot and mouth disease vaccines and methods for their production and use.